FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)
- Status
- COMPLETED
- Phase
- PHASE2
Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab And Lenvatinib In Leptomeningeal Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Status
- RECRUITING
- Phase
- PHASE2
TAC T-cells for the Treatment of HER2-positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NICSO National Study: Physician - Nurse Monitoring Project About Oncological Adverse Events
- Status
- COMPLETED
- Phase
- NA
Keep Contraceptive Arm Long Acting-iMplant (CALM) and Carry On
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002)
- Status
- COMPLETED
- Phase
- PHASE2
A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Liver Disease and in Age-, Weight- and Gender-matched Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Kidney Disease and in Age-, Weight- and Gender-matched Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1